您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 103-110.doi: 10.6040/j.issn.1671-7554.0.2020.1656

• 临床医学 • 上一篇    下一篇

沉默PRRX1基因表达可增强前列腺癌耐药细胞株PC-3/DTX对多西他赛的敏感性

徐兵1,李勇2,刘明1,刘永辉1   

  1. 1.南华大学附属第三医院泌尿外科, 湖南 衡阳 421900;2.南华大学附属第二医院泌尿外科, 湖南 衡阳 421900
  • 发布日期:2021-06-10
  • 通讯作者: 徐兵. E-mail:hanbin9699@126.com
  • 基金资助:
    2018年湖南省教育厅科学研究项目(18C0470)

Silencing PRRX1 gene expression enhances the sensitivity of prostate cancer resistant cell line PC-3/DTX to docetaxel

XU Bing1, LI Yong2, LIU Ming1, LIU Yonghui1   

  1. 1. Department of Urology, The Third Affiliated Hospital of Nanhua University, Hengyang 421900, Hunan, China;
    2. Department of Urology, The Second Affiliated Hospital of Nanhua University, Hengyang 421900, Hunan, China
  • Published:2021-06-10

PDF (PC)

353

摘要： 目的 探讨配对相关同源框1(PRRX1)基因沉默对前列腺癌耐药细胞多西他赛(DTX)敏感性的影响及可能机制。 方法 临床收集35例DTX化疗敏感患者(DTX-S)和29例DTX化疗耐药患者(DTX-R)的癌组织。采用qRT-PCR法检测癌组织中PRRX1 mRNA表达水平。体外培养人前列腺癌PC-3细胞,采用DTX浓度递增间断刺激法建立DTX耐药细胞株PC-3/DTX。采用qRT-PCR法和Western blotting法检测耐药株PC-3/DTX及其亲本PC-3细胞中PRRX1 mRNA和蛋白表达水平;通过siRNA沉默PC-3/DTX细胞PRRX1基因表达,采用qRT-PCR和Western blotting检测转染后PC-3/DTX细胞中PRRX1 mRNA和蛋白表达水平;DTX干预转染后PC-3/DTX细胞24 h,采用MTT法检测细胞增殖活性,计算半数抑制浓度(IC50)和耐药指数(RI);采用流式细胞术检测细胞凋亡情况;采用Western blotting法检测细胞中cleaved caspase-3、p-mTOR、mTOR、Beclin-1和LC-3蛋白表达水平。 结果 DTX-R癌组织中PRRX1 mRNA表达水平高于DTX-S癌组织(6.59±1.49 vs 1.07±0.34),差异有统计学意义(F=656.401,P<0.05)。耐药细胞株PC-3/DTX及其亲本PC-3细胞对不同浓度DTX作用24 h后的IC50值分别为(89.88±6.86)nmol/L和(15.56±1.45)nmol/L,RI值为5.78。耐药细胞株PC-3/DTX中PRRX1 mRNA和蛋白表达水平高于其亲本PC-3细胞(mRNA:9.22±1.50 vs 1.00±0.17;蛋白:0.50±0.04 vs 0.08±0.02),差异有统计学意义(FmRNA=59.05,F蛋白=171.70,P<0.05)。PRRX1基因沉默后,PC-3/DTX细胞中PRRX1 mRNA和蛋白表达水平降低(mRNA:1.01±0.02 vs 0.98±0.04 vs 0.22±0.10;蛋白:0.62±0.01 vs 0.61±0.01 vs 0.11±0.01),差异有统计学意义(FmRNA=122.01,F蛋白=554.53,P<0.05)。沉默PRRX1基因可降低PC-3/DTX细胞对DTX的耐药性,促进细胞凋亡,并上调p-mTOR和cleaved caspase-3水平,下调Beclin-1和LC-3蛋白表达水平,差异有统计学意义(P<0.05)。 结论 沉默PRRX1基因表达可增强前列腺癌耐药细胞株PC-3/DTX对DTX的敏感性,其机制可能与激活mTOR信号通路进而抑制细胞自噬有关。

关键词: 基因沉默, 配对相关同源框1, 前列腺癌, 多西他赛, 耐药, 细胞自噬

Abstract: Objective To explore the effects of paired-related homeobox 1(PRRX1)gene silencing on the sensitivity of drug-resistant prostate cancer cells to docetaxel(DTX)and the possible mechanism. Methods The cancer tissues of 35 patients who were DTX chemotherapy sensitive(DTX-S)and 29 patients who were DTX chemotherapy resistant(DTX-R)were collected. The mRNA expression of PRRX1 in cancer tissues was detected with qRT-PCR. Human prostate cancer PC-3 cells were cultured in vitro, and the DTX-resistant cell line PC-3/DTX was established by increasing DTX concentration intermittently. The mRNA and protein expressions of PRRX1 in the drug-resistant PC-3/DTX and the parental PC3 cells were detected with qRT-PCR and Western blotting. The expression of PRRX1 gene in PC-3/DTX cells was silenced by siRNA, and the mRNA and protein expressions of PRRX1 in PC-3/DTX cells after transfection were detected with qRT-PCR and Western blotting. After DTX intervention, PC-3/DTX cells were transfected for 24 hours. The cell proliferation was detected with MTT, and the half inhibitory concentration(IC50)and drug resistance index(RI)were calculated. The cell apoptosis was detected with flow cytometry. The protein expressions of cleaved caspase-3, p-mTOR, mTOR, Beclin-1 and LC-3 were detected with Western blotting. Results The mRNA expression of PRRX1 in DTX-R cancer was higher than that in DTX-S cancer(6.59±1.49 vs 1.07±0.34)(F=656.401, P<0.05). The IC50 values of the drug-resistant cell line PC-3/DTX and the parental PC-3 cells treated with different concentrations of DTX for 24 h were(89.88±6.86)nmol/L and(15.56±1.45)nmol/L, respectively, and the RI was 5.78. The mRNA and protein expressions of PRRX1 in the drug-resistant cell line PC-3/DTX were higher than those in the parental PC-3 cells(mRNA: 9.22±1.50 vs 1.00±0.17; protein: 0.50±0.04 vs 0.08±0.02)(FmRNA=59.05, Fprotein=171.70, P<0.05). After the PRRX1 gene was silenced, the mRNA and protein expressions of PRRX1 in PC-3/DTX cells reduced(mRNA: 1.01±0.02 vs 0.98±0.04 vs 0.22±0.10; protein: 0.62±0.01 vs 0.61±0.01 vs 0.11±0.01)(FmRNA=122.01, Fprotein=554.53, P<0.05). Silencing the PRRX1 gene reduced the resistance of PC-3/DTX cells to DTX, promoted cell apoptosis, and up-regulated the expressions of p-mTOR and cleaved caspase-3, and down-regulated the protein expressions of Beclin-1 and LC-3(P<0.05). Conclusion Silencing the expression of the PRRX1 gene can enhance the sensitivity of the prostate cancer drug-resistant cell line PC-3/DTX to DTX, and the mechanism may be related to the activation of the mTOR signaling pathway to inhibit autophagy.

Key words: Gene silencing, Paired related homeobox 1, Prostate cancer, Docetaxel, Drug resistance, Autophagy

中图分类号: 

  • R737.1
[1] Zhu Y, Freedland SJ, Ye D. Prostate cancer and prostatic diseases best of Asia, 2019: challenges and opportunities [J]. Prostate Cancer Prostatic Dis, 2020, 23(2): 197-198.
[2] Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells [J]. Cancer Cell, 2012, 22(3): 373- 388.
[3] 李宁宁, 郭振英. PRRX1 在 EMT 及维持肿瘤干性中的研究进展[J]. 临床与实验病理学杂志, 2018, 34(4): 83-85. LI Ningning, GUO Zhenying. Research progress of PRRX1 in EMT and maintenance of tumor dryness [J]. Chinese Journal of Clinical and Experimental Pathology, 2018, 34(4): 83-85.
[4] Dong J, Lv Z, Chen Q, et al. PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells [J]. Int J Clin Exp Pathol, 2018, 11(5): 2629-2635.
[5] Wang S, Ping M, Song B, et al. Exosomal circ PRRX1 enhances doxorubicin resistance in gastric cancer by regulating miR-3064-5p/PTPN14 signaling [J]. Yonsei Med J, 2020, 61(9): 750-761.
[6] 朱小长, 陶连元, 杜瀛瀛, 等. mTOR抑制剂通过mTOR通路介导胰腺癌顺铂耐药的机制研究[J]. 安徽医科大学学报, 2019, 54(8): 1205-1210. ZHU Xiaozhang, TAO Lianyuan, DU Yingying, et al. Mechanism of mTOR inhibitors in cisplatin resistance in pancreatic cancer by mediating the mTOR pathway [J]. Acta Universitatis Medicinalis Anhui, 2019, 54(8): 1205-1210.
[7] Gremke N, Polo P, Dort A, et al. mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability [J]. Nat Commun, 2020, 11(1): 4684.
[8] 马琪, 李永红, 杨斌, 等. 前列腺癌化疗安全共识[J]. 现代泌尿外科杂志, 2018, 23(2): 85-92. MA Qi, LI Yonghong, YANG Bin, et al. Consensus on the safety of chemotherapy for prostate cancer [J]. Journal of Modern Urology, 2018, 23(2): 85-92.
[9] 林建中, 朱佳庚, 吴宏飞, 等. AXL表达在前列腺癌细胞多西他赛耐药中的作用研究[J]. 中华男科学杂志, 2017, 23(4): 302-308. LIN Jianzhong, ZHU Jiageng, WU Hongfei, et al. Expression of AXL enhances docetaxel-resistance of prostate cancer cells [J]. National Journal of Andrology, 2017, 23(4): 302-308.
[10] Li Y, Yang R, Henzler CM, et al. Diverse AR gene rearrangements mediate resistance to androgen receptor inhibitors in metastatic prostate cancer [J]. Clin Cancer Res, 2020, 26(8): 1965-1976.
[11] 王仕钦, 江春, 黄卫, 等. 普萘洛尔抑制前列腺癌发展的分子机制[J]. 医药导报, 2020, 39(6): 763-769. WANG Shiqin, JIANG Chun, HUANG Wei, et al. Molecular mechanisms of propranolol inhibits the progression of prostate cancer [J]. Herald of Medicine, 2020, 39(6): 763-769.
[12] Spreafico A, Chi KN, Sridhar SS, et al. A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients [J]. Invest New Drugs, 2014, 32(5): 1005-1016.
[13] 范钰, 蒋孟林, 满昌峰, 等. 配对相关同源框-1基因过表达对人胰腺癌细胞侵袭及上皮-间充质转化的影响[J]. 中华实验外科杂志, 2016, 33(7): 1789-1791. FAN Yu, JIANG Menglin, MAN Changfeng, et al. Effects of overexpression of paired-related homeobox 1 gene on invasion and epithelial mesenchymal transition of human pancreatic cancer cells [J]. Chinese Journal of Experimental Surgery, 2016, 33(7): 1789-1791.
[14] Tang Y, Lu Y, Chen Y, et al. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1 [J]. J Exp Clin Cancer Res, 2019, 38(1): 473.
[15] Hirata H, Sugimachi K, Takahashi Y, et al. Downregulation of PRRX1 confers cancer stem cell-like properties and predicts poor prognosis in hepatocellular carcinoma [J]. Ann Surg Oncol, 2015, 22(Suppl 3): 1402-1409.
[16] Nagai MH, Xavier VPS, Gutiyama LM, et al. Depletion of Ric-8B leads to reduced mTORC2 activity [J]. PLoS Genet, 2020, 16(5): 1008255.
[17] Murugan AK. mTOR: role in cancer, metastasis and drug resistance [J]. Semin Cancer Biol, 2019, 59: 92-111. doi: 10.1007/978-3-030-20301-6_15.
[18] Cristofani R, Montagnani MM, Cicardi ME, et al. Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells [J]. Cell Death Dis, 2018, 9(9):889.
[19] Smith AG, Macleod KF. Autophagy, cancer stem cells and drug resistance [J]. J Pathol, 2019, 247(5): 708-718.
[1] 葛丽娟 金瑞峰 王纪文 许新升 李癊. 多药耐药基因1 C1236T多态性与癫痫患者对药物反应性的相关性[J]. 山东大学学报(医学版), 2209, 47(6): 99-102.
[2] 孙浩瑜,姜鑫,陈守臻,曲思凤,史本康. 多参数磁共振联合前列腺健康指数对PSA灰区临床有意义前列腺癌的诊断价值[J]. 山东大学学报 (医学版), 2022, 60(6): 46-50.
[3] 许振,刁统祥,臧振杰,邵丁昌,张奇,孙鼎琪,傅强. 前列腺特异性抗原同源异构体2及其衍生指标在前列腺癌诊断中的价值[J]. 山东大学学报 (医学版), 2022, 60(6): 51-56.
[4] 李燕,刘静,李娟,杨秋红. 50例孕产妇血流感染临床特征及胎盘病理分析[J]. 山东大学学报 (医学版), 2022, 60(1): 48-54.
[5] 鞠建华,杨镇业,李青连,韩亚楠,李艳青,乔伊君,杨虎,张华然. 微生物药物研究开发现状与思考[J]. 山东大学学报 (医学版), 2021, 59(9): 43-50,63.
[6] 哈春芳,李茹月. 卵巢癌耐药机制与靶向治疗策略的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 117-123.
[7] 史本康,陈守臻,曲思凤,王勇,刘磊. 临床常见快速进展前列腺癌临床特点及研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 110-116.
[8] 孙鼎琪,傅强,张辉,刘帅,刁统祥,曹庆伟,张克勤. 多参数磁共振与经直肠超声融合前列腺靶向穿刺活检在检测PI-RADS≥3前列腺癌中的临床价值[J]. 山东大学学报 (医学版), 2021, 59(4): 108-113.
[9] 丁菲,姜洁. 姜黄素对子宫内膜癌孕激素抵抗的影响[J]. 山东大学学报 (医学版), 2021, 59(4): 35-41.
[10] 赵立红,赵书平,聂升刚,孙晶,姜同峰. 507例男性生殖道感染病原体分布及耐药特征[J]. 山东大学学报 (医学版), 2021, 59(1): 55-58.
[11] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31.
[12] 孙艳婷,吴大玮,王晓斐,徐建,王睿. 新建医院ICU临床分离菌的分布及耐药变迁[J]. 山东大学学报 (医学版), 2020, 58(2): 64-71.
[13] 付振美,马铭泽. 溃疡性结肠炎患者肠黏膜P糖蛋白的表达及其临床意义[J]. 山东大学学报 (医学版), 2020, 58(12): 54-59.
[14] 张宁,杨燕,李锐,殷运红,李昊,曲仪庆. 慢阻肺患者感染鲍曼不动杆菌危险因素及耐药性分析[J]. 山东大学学报 (医学版), 2019, 57(9): 88-96.
[15] 潘艳艳,孙永超,刘雪梅,张洪霞,周蔚然,赵翠芬. 尿液α1-抗胰蛋白酶、尿转铁蛋白水平与小儿原发性肾病综合征激素治疗效果的关联分析[J]. 山东大学学报 (医学版), 2019, 57(12): 74-79.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 王焕亮,孙宝柱,杜洪玫,周长青,张丽. 不同麻醉监测指标调控异丙酚麻醉的比较[J]. 山东大学学报(医学版), 2006, 44(5): 471 -474 .
[2] 朱梅佳,韩巨,王新怡,鹿伟,王爱华,关心华,曹霞,曹秉振. 伴有皮层下梗死和白质脑病的常染色体显性遗传性脑动脉病临床病理研究[J]. 山东大学学报(医学版), 2006, 44(8): 834 -839 .
[3] 宋海岩,武玉玲,张艳萍. 牡蛎提取物对高温致神经管畸形中凋亡细胞的保护作用[J]. 山东大学学报(医学版), 2007, 45(2): 113 -116 .
[4] 王志刚,丁　璇,孙　鹏/sup>,王成伟,郝晓光,潘　顺 . 术前脑血管造影在血管内支架成形术治疗缺血性脑血管病中的应用[J]. 山东大学学报(医学版), 2007, 45(2): 146 -148 .
[5] 曾季平,王丽娜,王立祥,任晓辉,张孟业,夏文,崔行. 氯化锰致PC12细胞损伤的研究[J]. 山东大学学报(医学版), 2006, 44(5): 467 -470 .
[6] 舒雅,齐峰. 下颌角托在肥胖患者全麻诱导中的应用[J]. 山东大学学报(医学版), 2007, 45(10): 1072 -1074 .
[7] 于慧1,2 ，陈少华1 ，赵家军2 ，高聆3
. 乙醇对人肝L02细胞糖原和GSK3β、PAMPK的影响[J]. 山东大学学报(医学版), 2009, 47(04): 75 -78 .
[8] 宋永红,马春红,吕红娟,朱传福,聂向民,王玫,刘艳,张萍 . 中国北方汉族人群HLA基因多态性研究[J]. 山东大学学报(医学版), 2007, 45(6): 546 -553 .
[9] 张向丽,刘凤英 . 血清TPA、 sVCAM-1与子痫前期发病关系的初步探讨[J]. 山东大学学报(医学版), 2007, 45(7): 705 -707 .
[10] 郑金旭 顾燕兰 万兵. 糜酶抑制剂对肺纤维化的干预作用及其机制研究[J]. 山东大学学报(医学版), 2008, 46(12): 1132 -1135 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发